By Disabled People for Disabled People
Let's focus on what we can do, not what we can't!
Essential Pharma, the manufacturer of Priadel, has said the drug is no longer a viable product “due to restrictions on permitted pricing”
The Royal Pharmaceutical Society (RPS) has said it is ”deeply concerned” and warned of the “huge extra cost” to the NHS after a manufacturer announced plans to discontinue production of one of its branded lithium carbonate products.
In August 2020, Essential Pharma said it would be discontinuing production of Priadel 200mg and 400mg — used as a first-line treatment for bipolar disorder — in April 2021 “due to restrictions on permitted pricing”, making the product “no longer viable”.
Click here to read full article https://www.pharmaceutical-journal.com/news-and-analysis/news/rps-warns-of-huge-extra-cost-to-nhs-after-bipolar-drug-withdrawn/20208308.article
By clicking “submit,” you agree to receive emails from Ability Today and accept our web terms of use and privacy and cookie policy.
By clicking “submit,” you agree to receive emails from Ability Today and accept our web terms of use and privacy and cookie policy.
